Trade TransMedics Group Inc - TMDX CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.20 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.023512% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.00129% | ||||||||
| Overnight fee time | 22:00 (UTC) | ||||||||
| Min traded quantity | 0.1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 75.35 |
| Open | 74.45 |
| 1-Year Change | -15.83% |
| Day's Range | 71.7 - 76.2 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Feb 21, 2025 | 71.81 | -3.85 | -5.09% | 75.66 | 76.52 | 71.46 |
| Feb 20, 2025 | 75.35 | -3.94 | -4.97% | 79.29 | 79.87 | 75.35 |
| Feb 19, 2025 | 79.35 | 4.88 | 6.55% | 74.47 | 79.39 | 73.75 |
| Feb 18, 2025 | 74.96 | 1.66 | 2.26% | 73.30 | 75.87 | 72.77 |
| Feb 14, 2025 | 72.13 | 0.17 | 0.24% | 71.96 | 73.98 | 71.94 |
| Feb 13, 2025 | 71.13 | 1.36 | 1.95% | 69.77 | 71.21 | 67.75 |
| Feb 12, 2025 | 69.47 | 2.72 | 4.07% | 66.75 | 70.10 | 66.75 |
| Feb 11, 2025 | 68.00 | -1.23 | -1.78% | 69.23 | 71.94 | 67.44 |
| Feb 10, 2025 | 70.24 | -2.44 | -3.36% | 72.68 | 72.93 | 66.55 |
| Feb 7, 2025 | 72.60 | -1.36 | -1.84% | 73.96 | 74.95 | 72.15 |
| Feb 6, 2025 | 73.50 | -1.40 | -1.87% | 74.90 | 75.97 | 72.22 |
| Feb 5, 2025 | 74.46 | 1.96 | 2.70% | 72.50 | 75.06 | 72.50 |
| Feb 4, 2025 | 72.06 | 2.82 | 4.07% | 69.24 | 73.71 | 69.23 |
| Feb 3, 2025 | 68.68 | 4.12 | 6.38% | 64.56 | 69.19 | 64.20 |
| Jan 31, 2025 | 67.49 | 0.53 | 0.79% | 66.96 | 69.40 | 66.91 |
| Jan 30, 2025 | 66.87 | 1.00 | 1.52% | 65.87 | 67.90 | 64.49 |
| Jan 29, 2025 | 65.45 | -1.00 | -1.50% | 66.45 | 66.99 | 64.23 |
| Jan 28, 2025 | 66.95 | 5.65 | 9.22% | 61.30 | 66.99 | 60.38 |
| Jan 27, 2025 | 61.03 | 1.76 | 2.97% | 59.27 | 64.35 | 59.25 |
| Jan 24, 2025 | 60.77 | -1.79 | -2.86% | 62.56 | 63.86 | 60.11 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
TransMedics Group, Inc. Company profile
About TransMedics Group Inc
TransMedics Group, Inc. is a commercial-stage medical technology company. It is focused on developing organ transplant therapy for end-stage organ failure patients across multiple disease states. The Company has designed and developed organ care system (OCS) a portable organ perfusion, optimization and monitoring system that utilizes customized technology to replicate near-physiologic conditions for donor organs outside of the human body. It has developed three OCS products, one for each of lung, heart and liver transplantations. Its OCS clinical programs include OCS Heart EXPAND Trial, OCS Heart EXPAND Continued Access Protocol, or CAP, Trial and OCS Heart PROCEED II Trials. Its organ care system (OCS) technology platform to perfuse donor organs with warm, oxygenated, nutrient-enriched blood, while maintaining the organs in a living, functioning state; the lung is breathing, the heart is beating and the liver is producing bile.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, TransMedics Group Inc revenues increased 18% to $30.3M. Net loss increased 54% to $44.2M. Revenues reflect OCS Lung net revenue segment increase of 72% to $10.7M, OCS Heart net revenue segment increase of 25% to $17.7M, United States segment increase of 14% to $21.9M, All other countries segment increase of 31% to $8.4M.
| Industry: | Advanced Medical Equipment & Technology (NEC) |
200 Minuteman Road
ANDOVER
MASSACHUSETTS 01810
US
News
Microsoft Stock Price Forecast for 2025 and beyond: Third party price target
We assess the likely level of the Microsoft stock price in 5 years, and possible drivers behind the stock’s past performance. Read on...
18:29, 7 February 2025
Ripple XRP price prediction: Third-party price target
Discover the ripple (XRP) price predictions for 2025 and beyond, with analyst price targets and CFDs trading strategies on Capital.com
15:29, 6 February 2025
Apple (AAPL) stock price forecast: third-party price target
We looked at the forecasts for Apple stock in 10 years to see where the price would likely be at that point and the challenges the company could face. Read more.
11:22, 6 February 2025
FARTCOIN price prediction: Third-party price target
Read our FARTCOIN price prediction for 2025 and beyond, with insights from third-party analysts and market experts
10:18, 29 January 2025
MELANIA coin ($MELANIA) price prediction: Third party price target
Read our MELANIA crypto price prediction for 2025 and beyond, with insights from third-party analysts and market experts.
11:33, 22 January 2025
TRUMP coin ($TRUMP) price prediction: third-party price target
Read our TRUMP crypto price prediction for 2025 and beyond, with insights from third-party analysts and market experts
10:52, 22 January 2025
Ethereum price prediction: Third party data round up
What is the outlook for ETH as a long-term investment?
16:37, 7 January 2025People also watch
Still looking for a broker you can trust?
Join the 690,000+ traders worldwide that chose to trade with Capital.com